Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDrax Regulatory News (DRX)

Share Price Information for Drax (DRX)

Share Price is delayed by 15 minutes
Get Live Data
773.00    -11.50 (-1.47%)
Bid:
777.50
Ask:
778.00
Spread: 0.50 (0.064%)
Market Cap: £2.60b
DRX Live PriceLast checked at - London Stock Exchange

Intraday Drax Share Chart

Share Buyback Programme

2 Jun 2025 14:55

RNS Number : 0744L
Drax Group PLC
02 June 2025
 

2 June 2025

 

DRAX GROUP PLC

(Symbol: DRX)

 

Share Buyback Programme

 

On 28 February 2025, Drax Group plc (the "Company") announced that in connection with the up to £300 million share buyback programme announced on 26 July 2024 to purchase ordinary shares of 11 16/29 pence each in the Company (the "Programme"), it was commencing the third tranche of the Programme up to a maximum consideration of £75 million (the "Third Tranche"). As at 30 May 2025, the Company had repurchased a total of 36,102,728 shares for a consideration of c.£225 million in aggregate across the First, Second and Third Tranches.

 

The Company is today confirming that the fourth tranche of the Programme to purchase ordinary shares in the Company up to a maximum consideration of £75 million (the "Fourth Tranche") will now commence, following the conclusion of the Third Tranche on 30 May 2025.

 

The purpose of the Fourth Tranche is to reduce the Company's share capital. The ordinary shares purchased by the Company will be held in treasury pending cancellation or re-issue.

 

Ordinary share purchases as part of the Fourth Tranche will take place in open market transactions and may be made from time to time depending on market conditions, share price and trading volumes. The maximum number of shares that may be repurchased by the Company under the Fourth Tranche of the Programme is 33,469,342 being the number of shares the Company is authorised to purchase pursuant to the authority granted by shareholders at the AGM on 1 May 2025 less the shares acquired under the Third Tranche since 1 May 2025.

 

The programme will be carried out through an irrevocable non-discretionary agreement with J.P. Morgan Securities plc ("JPMS plc"), pursuant to which JPMS plc shall purchase ordinary shares as riskless principal (and not as agent of the Company) for the subsequent sale on to, and purchase by, the Company. JPMS plc will make its trading decisions in relation to the ordinary shares independently of, and uninfluenced by, the Company.

 

This arrangement is in accordance with Chapter 9 of the United Kingdom Financial Conduct Authority Listing Rules and the Company's general authority to repurchase shares.

 

The Company will make further announcements in due course following the buyback of shares. Note there is no guarantee that the Programme will be implemented in full.

 

Capitalised terms relate to the Company's announcements on 7 August 2024, 22 October 2024 and 28 February 2025 unless specified otherwise.

 

Enquiries:

Drax Investor Relations: Mark Strafford

+44 (0) 7730 763 949

 

Media:

Drax External Communications: Chris Mostyn

+44 (0) 7743 963 483

 

J.P. Morgan

Robert Constant / Alia Malik

+44 (0) 20 3493 8000

 

Website: www.drax.com

 

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCKZGGVFZZGKZM
Date   Source Headline
25th Sep 20245:16 pmRNSTransaction in Own Shares
25th Sep 20242:56 pmRNSHolding(s) in Company
23rd Sep 20245:34 pmRNSTransaction in Own Shares
20th Sep 20245:52 pmRNSTransaction in Own Shares
19th Sep 20245:36 pmRNSTransaction in Own Shares
18th Sep 20245:49 pmRNSTransaction in Own Shares
17th Sep 20245:52 pmRNSTransaction in Own Shares
16th Sep 20245:36 pmRNSTransaction in Own Shares
13th Sep 20245:40 pmRNSTransaction in Own Shares
12th Sep 20245:39 pmRNSTransaction in Own Shares
11th Sep 20245:59 pmRNSTransaction in Own Shares
10th Sep 20245:43 pmRNSTransaction in Own Shares
9th Sep 20245:58 pmRNSTransaction in Own Shares
6th Sep 20245:38 pmRNSTransaction in Own Shares
5th Sep 20245:50 pmRNSTransaction in Own Shares
4th Sep 20246:05 pmRNSTransaction in Own Shares
4th Sep 20249:00 amRNSDirector/PDMR Shareholding
3rd Sep 20245:51 pmRNSTransaction in Own Shares
3rd Sep 20247:00 amRNSTransaction in Own Shares
2nd Sep 202410:15 amRNSTotal Voting Rights
30th Aug 20246:10 pmRNSTransaction in Own Shares
29th Aug 20245:44 pmRNSTransaction in Own Shares
29th Aug 20247:10 amRNSClosure of Ofgem investigation
28th Aug 20245:45 pmRNSTransaction in Own Shares
27th Aug 20245:51 pmRNSTransaction in Own Shares
23rd Aug 20245:29 pmRNSTransaction in Own Shares
22nd Aug 20245:44 pmRNSTransaction in Own Shares
21st Aug 20245:32 pmRNSTransaction in Own Shares
20th Aug 20245:50 pmRNSTransaction in Own Shares
20th Aug 20244:32 pmRNSHolding(s) in Company
20th Aug 20247:00 amRNSNew sustainability-linked £450m RCF
19th Aug 20246:07 pmRNSTransaction in Own Shares
19th Aug 20242:59 pmRNSNotice of change to director details
16th Aug 20245:50 pmRNSTransaction in Own Shares
16th Aug 20247:00 amRNSTransaction in Own Shares
15th Aug 20247:00 amRNSTransaction in Own Shares
13th Aug 20245:51 pmRNSTransaction in Own Shares
13th Aug 20247:00 amRNSTransaction in Own Shares
9th Aug 20246:10 pmRNSTransaction in Own Shares
8th Aug 20246:05 pmRNSTransaction in Own Shares
7th Aug 20246:12 pmRNSTransaction in Own Shares
7th Aug 20247:00 amRNSShare Buyback Programme
2nd Aug 202412:02 pmRNSHolding(s) in Company
1st Aug 202412:12 pmRNSDirector/PDMR Shareholding
1st Aug 202410:44 amRNSTotal Voting Rights
26th Jul 20247:00 amRNSHalf-year Report
19th Jul 202410:36 amRNSNotice of Results
12th Jul 202412:03 pmRNSHolding(s) in Company
12th Jul 202411:33 amRNSHolding(s) in Company
10th Jul 20244:10 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.